Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture

Drug and Alcohol Dependence

Volumn 54, Issue 3, 1999, Pages 183-194

  Freedland, Cory S ^a,c   Mansbach, Robert S ^b  

^a The Holleran Center for Community Action and Public Policy   (United States)

^b PFIZER INC   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Ayahuasca; Dimethyltryptamine; Ethnopharmacology; Functional observational battery; Harmine; Mice

Indexed keywords

BANISTERIOPSIS CAAPI EXTRACT; BETA CARBOLINE DERIVATIVE; HARMINE; N,N DIMETHYLTRYPTAMINE; NP 25971; PLANT EXTRACT; PSYCHEDELIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ETHNOPHARMACOLOGY; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLANT; PRIORITY JOURNAL; STARTLE REFLEX;

ANIMALS; BEHAVIOR, ANIMAL; HALLUCINOGENS; HARMINE; MALE; MICE; MOTOR ACTIVITY; N,N-DIMETHYLTRYPTAMINE; PLANTS, MEDICINAL; PSYCHOTROPIC DRUGS;

BANISTERIOPSIS CAAPI; PSYCHOTRIA VIRIDIS;

EID: 0032987251     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00154-9     Document Type: Article

References (33)

1. Andritzky, W., 1989. Sociopsychotherapeutic functions of ayahuasca healing in amazonia. J. Psychoact. Drugs 21, 77-89.
2. Buckholtz, N.S., Boggan, W.O., 1977. Monoamine oxidase inhibition in brain and liver produced by β-carbolines: structure activity relationships and substrate specificity. Biochem. Pharmacol. 26, 1991-1996.
3. Callaway, J.C., Airaksinen, M.M., McKenna, D.J., Brito, G.S., Grob, C.S., 1994. Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology 116, 385-387.
4. Callaway, J.C., Raymon, L.P., Hearn, W.L., McKenna, D.J., Grob, C.S., Brito, G.S., Mash, D.C., 1996. Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. J. Anal. Toxicol. 20, 492-497.
5. Costa, E., Guidotti, A., Mao, C.C., Suria, A., 1975. New concepts of the mechanism of action of benzodiazepines. Life Sci. 17, 167-186.
6. Dobkin de Rios, M., 1972. Visionary Vine: Hallucinogenic Healing in the Peruvian Amazon. Chandler, San Francisco, CA, USA.
7. Gates, B., 1982. A monograph of Banisteriopsis and Diplopterys, Malpighaceae. Flora Neotropica 30, New York Botanical Garden, New York.
8. Glennon, R.A., Young, R., Rosecrans, J.A., 1983. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur. J. Pharmacol. 91, 189-196.
9. Grob, C.S., McKenna, D.J., Callaway, J.C., Brito, G.S., Neves, E.S., Oberlander, G., Saide, O.L., Labigalini, E., Talca, C., Miranda, C.T., Strassman, R.J., Boone, K.B., 1996. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J. Nerv. Ment. Dis. 184, 86-94.
10. Harner, M.J., 1973. Hallucinogens and Shamanism. Oxford University Press, London.
11. Ho, B.T., 1977. Pharmacological and biochemical studies with β-carboline analogs. In: Essman, W.B., Vazelli, L. (Eds.), Current Developments in Psychopharmacolgy, vol. 4. Spectrum, New York, pp. 155-177.
12. Kawanishi, K., Eguchi, N., Hayashi, T., Hashimoto, Y., 1994. Relationship between occurance of tremor/convulsion and level of β-carbolines in the brain after administration of β-carbolines into mice. Pharm. Biochem. Behav. 47, 689-699.
13. Kelly, D.M., Nayler, R.J., 1974. Mechanisms of tremor induced by harmine. Eur. J. Pharmacol. 27, 14-24.
14. Mabit, M., 1996. Takiwasi: ayahuasca and shamanism in addiction therapy. MAPS Newslett. 6, 24-27.
15. Martin, P., Frances, H., Simon, P., 1985. Dissociation of head twitches and tremors during the study of interactions with 5-Hydroxytryptophan in mice. J. Pharmacol. Methods 13, 193-200.
16. McKenna, D.J., 1996. Plant hallucinogens: springboards for psychotherapeutic drug discovery. Behav. Brain Res. 73, 109-116.
17. McKenna, D.J., Towers, G.H.N., 1984. Biochemistry and pharmacology of tryptamines and β-carbolines: a minireview. J. Psychoact. Drugs 10, 195-223.
18. McKenna, D.J., Towers, G.H.N., Abbot, F., 1984. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of ayahuasca. J. Ethnopharmacol. 11, 189-206.
19. Moser, V.C., McCormick, J.P., Creason, J.P., MacPhail, R.C., 1988. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam. Appl. Toxic. 11, 189-206.
20. Ott, J., 1994. Ayahuasca Analogues. Natural Products, Kennewick, WA, USA.
21. Rivier, L., Lindgren, L., 1972. Ayahuasca, the South American hallucinogenic drink: an ethnobotanical and chemical investigation. Econ. Botany 26, 101-129.
22. Sipes, T.E., Geyer, M.A., 1997. DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum. Brain Res. 761, 97-104.
23. Spruce, R., 1908. Notes of a Botanist on the Amazon and Andes. MacMillan, London.
24. Sternbach, H., 1991. The serotonin syndrome. Am. J. Psychiatr. 148, 705-713.
25. Strassman, R.J., Qualls, C.R., 1994. Dose-response study of N,N-dimethyltryptamine in humans. I: neuroendocrine, autonomic, and cardiovascular effects. Arch. Gen. Psychiat. 51, 85-97.
26. Strassman, R.J., Qualls, C.R., Uhlenhuth, E.H., Kellner, R., 1994. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch. Gen. Pharmacol. 51, 98-108.
27. Strassman, R.J., Qualls, C.R., Berg, L.M., 1996. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biol. Psychiat. 39, 784-795.
28. Szara, S.I., 1956. Dimethyltryptamin: its metabolism in man; the relation of its psychotic effect to serotonin metabolism. Experientia 15, 441-442.
29. Szara, S.I., 1957. The comparison of the psychotic effect of tryptamine derivatives with the effects of mescaline and LSD-25 in self-experiments. In: Garattini, S., Ghetti, V. (Eds.), Psychotropic Drugs. Elsevier, Amsterdam, pp. 460-467.
30. Tegeris, J.S., Balster, R.L., 1994. A comparison to the acute behavioral effects of alkylbenzenes using a functional observational battery in mice. Fundam. Appl. Toxicol. 22, 240-250.
31. Wilkinson, L.O., Dourish, C.T., 1991. Serotonin and animal behavior. In: Peroutka, J. (Ed.), Serotonin Receptor Subtypes: Basic and Clinical Aspects. Wiley-Liss, pp. 147-210.
32. Yamazaki, M., Tanaka, C., Takaori, S., 1979. Significance of central noradrenergic system on harmaline induced tremor. Pharm. Biochem. Behav. 10, 421-429.
33. Young, R., Rosecrans, J.A., Glennon, R.A., 1982. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD. Life Sci. 30, 2057-2062.